Again if it worries you I suggest it’s not the type of investment you should be buy , as a matter a fact you probably should not be investing in any biotec . As I said in my previous statement Oncosil don’t get to set the protocol for these studies , the controlling body does as it’s a safety study . Oncosil might have liked to use a bigger dose but they don’t get to choose . Now the main study has been done you will find even the people who did not achive large enough shrinkage of their tumors for a resection might get reimplanted and further patients will get larger doses now they know the implants are safe and effective . Even when this implant procedure is approved different Oncologists will use different procedures and Chemo treatments to help their patients . Before you know it we could be well over 30% success rate
OSL Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)